Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|17|9|782-805

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.17, Iss.9, 2017-10, pp. : 782-805

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple Myeloma Bone Marrow Niche

By  

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 3, 2009-04 ,pp. : 335-346

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple Myeloma and the Immune Microenvironment

By  

Current Cancer Drug Targets, Vol. 17, Iss. 9, 2017-10 ,pp. : 806-818

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Signaling Pathways in Multiple Myeloma

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 6, 2006-12 ,pp. : 407-413

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Bone Marrow Transplantation in the Disease Pathway of Myeloma

By Harousseau Jean-Luc   Moreau Philippe  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 2, 2007-02 ,pp. : 163-169

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Targeting signalling pathways for the treatment of multiple myeloma

By Podar Klaus   Hideshima Teru   Chauhan Dharminder   Anderson Kenneth C  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 359-381

Informa Healthcare

Access to resources Recommend Favorite